Azithromycin dihydrate has been evaluated across numerous clinical trials spanning Early Phase 1 through Phase 4, investigating its efficacy in infectious diseases, chronic lung conditions, urogenital infections, viral illnesses like SARS-CoV-2, and rickettsial clearance. Ranging in status from active recruitment and completed studies to withdrawn or terminated protocols, these investigations are supported by academic medical centers, municipal hospital networks, and major international organizations including the Bill & Melinda Gates Foundation and the Wellcome Trust.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT06461429 | NOT_YET_RECRUITING | Preterm Birth |
University of Melbourne |
2025-11-01 | |
| NCT07485010 | NOT_YET_RECRUITING | Mycobacterium Abscessus Pulmonary Disease; Mycobacterium Abscessus Infection; Non-Tuberculous Mycobacterial (NTM) Infections; Non-Tuberculous Mycobacteria Pulmonary Disease |
The University of Queensland |
2027-04 | PHASE2 |
| NCT07625228 | NOT_YET_RECRUITING | Rheumatic Fever; Valvular Heart Diseases; Valvular Cardiomyopathy |
Ladoke Akintola University of Technology, Ogbomoso, Nigeria |
2027-01-05 | |
| NCT05763693 | NOT_YET_RECRUITING | Neonatal Death; Infectious Disease; Nutritional Deficiency |
University of California, San Francisco |
2026-04 | PHASE4 |
| NCT06906757 | NOT_YET_RECRUITING | PPROM; Preterm |
University of Melbourne |
2025-09 | |
| NCT07052942 | RECRUITING | Asthma; Asthma Attack; Asthma Exacerbations |
DARTNet Institute |
2025-08-01 | PHASE4 |
| NCT06289647 | WITHDRAWN | Trachoma |
University of California, San Francisco |
2024-10 | PHASE4 |
| NCT07433426 | RECRUITING | Diarrhea Infectious; Shigella; Growth & Development |
Johns Hopkins Bloomberg School of Public Health |
2026-03-18 | PHASE2 |
| NCT04310930 | RECRUITING | Pulmonary Disease Due to Mycobacteria (Diagnosis) |
The University of Queensland |
2020-03-02 | PHASE2; PHASE3 |
| NCT07183462 | RECRUITING | Pregnancy Complications, Infectious; Premature Birth; Neonatal Diseases and Abnormalities; Antibiotic Prophylaxis; Latency Period; Prematurity |
Sheba Medical Center |
2025-09-10 | PHASE4 |
| NCT06349122 | NOT_YET_RECRUITING | Bacterial Vaginosis; Vaginal Dysbiosis; Premature Delivery |
Assistance Publique Hopitaux De Marseille |
2026-10 | PHASE3 |
| NCT07306234 | NOT_YET_RECRUITING | Mycoplasma Pneumoniae; Mycoplasma Pneumoniae Pneumonia |
Young June Choe |
2026-03-01 | PHASE4 |
| NCT06082037 | RECRUITING | Lung Transplant Rejection |
Sanofi |
2023-10-10 | PHASE3 |
| NCT04669717 | RECRUITING | Periodontal Diseases; Antibiotics; Pharmacokinetics |
University of Geneva, Switzerland |
2021-09-01 | PHASE4 |
| NCT06488781 | RECRUITING | Obesity in Pregnancy; Labor Complication |
University of Oklahoma |
2025-04-29 | PHASE2 |
| NCT06325293 | RECRUITING | Community Acquired Pneumonia in Children; Mycoplasma Pneumoniae; Mycoplasma Pneumoniae Pneumonia |
Christoph Berger |
2025-01-28 | |
| NCT05580666 | RECRUITING | HIV Disease Progression |
Population Health Research Institute |
2023-05-08 | PHASE3 |
| NCT04381936 | RECRUITING | Pneumonia |
University of Oxford |
2020-03-19 | PHASE3 |
| NCT07213765 | RECRUITING | Mycobacterium Avium Complex Pulmonary Disease |
Bin Cao |
2025-07-24 | PHASE4 |
| NCT06010719 | RECRUITING | Malnutrition, Child; Severe Acute Malnutrition |
University of California, San Francisco |
2024-10-23 | PHASE4 |
| NCT05772013 | RECRUITING | Chronic Obstructive Pulmonary Disease |
Dr Ian B Wilkinson |
2024-03-05 | PHASE4 |
| NCT07608562 | NOT_YET_RECRUITING | Cervical Insufficiency |
Wake Forest University Health Sciences |
2026-09 | PHASE4 |
| NCT07669207 | RECRUITING | Preterm Prelabor Rupture of Membranes; PPROM |
Alexa Henderson |
2026-08-19 | PHASE4 |
| NCT06358872 | RECRUITING | Mortality; Antimicrobial Resistance |
University of California, San Francisco |
2024-04-29 | PHASE4 |
| NCT03236987 | RECRUITING | Lung Infection; MAC Lung Disease |
Centre Hospitalier Universitaire, Amiens |
2018-02-05 | PHASE3 |
| NCT06605118 | RECRUITING | Obstetrical Complications; Labor and Delivery Complication; Cesarean Delivery |
The George Washington University Biostatistics Center |
2024-11-06 | PHASE3 |
| NCT05157685 | RECRUITING | Sinusitis, Chronic; Sinus Infection Chronic |
Centre Hospitalier Intercommunal Creteil |
2022-11-21 | PHASE3 |
| NCT01233297 | ACTIVE_NOT_RECRUITING | Childhood Asthma With Acute Exacerbation |
Copenhagen Studies on Asthma in Childhood |
2010-11 | PHASE2 |
| NCT05922761 | RECRUITING | Bronchiolitis Obliterans Syndrome; Bronchiolitis Obliterans; Lung Diseases; Chronic Graft Versus Host Disease |
Dana-Farber Cancer Institute |
2024-05-31 | PHASE2 |
| NCT07608328 | NOT_YET_RECRUITING | Non-cystic Fibrosis Bronchiectasis; Bronchiectasis Adult; Bronchiectasis; Bronchiectasis With Acute Exacerbation |
Assiut University |
2026-05-21 | PHASE4 |
| NCT07615842 | NOT_YET_RECRUITING | Antibiotic Resistance Prevention |
University of Virginia |
2026-06-01 | PHASE1 |
| NCT06409299 | NOT_YET_RECRUITING | Tracheomalacia; Bronchopulmonary Dysplasia (BPD); Vascular Ring; Cystic Lung Disease; Bronchiectasis; Chronic Atelectasis |
Rigshospitalet, Denmark |
2024-09-01 | PHASE3 |
| NCT03335072 | ACTIVE_NOT_RECRUITING | Trachoma |
University of California, San Francisco |
2022-02-07 | PHASE4 |
| NCT07795086 | NOT_YET_RECRUITING | Chronic Obstructive Pulmonary Disease With Exacerbation |
Sidra Aziz |
2027-02 | PHASE4 |
| NCT07314281 | RECRUITING | Enteric Fever |
Indus Hospital and Health Network |
2025-04-22 | PHASE4 |
| NCT05842681 | RECRUITING | Idiopathic Pulmonary Fibrosis |
Assiut University |
2023-06-01 | |
| NCT07641348 | NOT_YET_RECRUITING | Typhoid Fever |
Iqra Asghar Ali |
2026-07-01 | |
| NCT07713186 | NOT_YET_RECRUITING | Atopic Dermatitis |
Cairo University |
2026-08-01 | PHASE4 |
| NCT03250975 | ACTIVE_NOT_RECRUITING | Intubation Complication |
Vanderbilt University Medical Center |
2017-08-19 | PHASE1; PHASE2 |
| NCT05847322 | RECRUITING | Healthy Volunteer Study |
University of Southampton |
2022-12-06 | |
| NCT05028153 | RECRUITING | Childhood Asthma With Acute Exacerbation |
Copenhagen Studies on Asthma in Childhood |
2022-11-14 | PHASE2 |
| NCT03083197 | ACTIVE_NOT_RECRUITING | Scrub Typhus |
University of Oxford |
2017-10-15 | PHASE4 |
| NCT05949190 | ACTIVE_NOT_RECRUITING | Malnutrition in Pregnancy; Preterm Birth; Child Development; Postpartum Depression; Antepartum Depression |
Washington University School of Medicine |
2023-08-18 | |
| NCT06543290 | RECRUITING | Infections |
Arrowhead Regional Medical Center |
2023-08-07 | PHASE1 |
| NCT05994742 | COMPLETED | Severe Acute Malnutrition; HIV; Comorbidities and Coexisting Conditions; Child Malnutrition |
Queen Mary University of London |
2024-07-15 | PHASE3 |
| NCT06273891 | ACTIVE_NOT_RECRUITING | Premature Rupture of Membrane |
Inova Health Care Services |
2024-03-08 | PHASE3 |
| NCT06618534 | COMPLETED | Meningococcal Infections |
Emory University |
2024-11-12 | PHASE2 |
| NCT05961189 | COMPLETED | Gastrointestinal Microbiome; Exercise |
Rutgers, The State University of New Jersey |
2023-09-01 | EARLY_PHASE1 |
| NCT07384793 | ACTIVE_NOT_RECRUITING | Acne Vulgaris II or III Degree |
Hayatabad Medical Complex |
2025-10-12 | PHASE4 |
| NCT03523156 | WITHDRAWN | Trachoma |
Emory University |
2025-06 | PHASE4 |
| NCT07777952 | COMPLETED | Acne Vulgaris |
Mahmoud Rageh |
2025-10-12 | |
| NCT04069312 | COMPLETED | Chronic Obstructive Pulmonary Disease Severe; Chronic Bronchitis |
Johns Hopkins University |
2020-02-11 | PHASE3 |
| NCT04339270 | UNKNOWN | Chronic Obstructive Pulmonary Disease |
University Hospital, Montpellier |
2023-02-03 | PHASE4 |
| NCT06715150 | NOT_YET_RECRUITING | Peri-implantitis |
University of Santiago de Compostela |
2025-01-10 | PHASE4 |
| NCT03672630 | COMPLETED | Mycobacterium Avium Complex; Nontuberculous Mycobacterium Infection |
Kevin Winthrop |
2019-02-22 | PHASE2; PHASE3 |
| NCT06170983 | UNKNOWN | Skin Infection |
Medical University of Vienna |
2024-01-01 | |
| NCT04921943 | RECRUITING | Nontuberculous Mycobacterial Lung Disease; Nontuberculous Mycobacterium Infection |
Oregon Health and Science University |
2021-05-18 | PHASE4 |
| NCT04349826 | COMPLETED | Typhoid Fever |
Oxford University Clinical Research Unit, Vietnam |
2021-05-23 | PHASE4 |
| NCT05398055 | UNKNOWN | Rocky Mountain Spotted Fever |
Hospital General de Mexicali |
2022-05-12 | PHASE3 |
| NCT05337566 | RECRUITING | Infection Post Op; Hysterectomy; Antibiotics; Prophylactic |
Helsinki University Central Hospital |
2022-09-05 | |
| NCT07445282 | COMPLETED | Extensively Drug-Resistant Typhoid Fever; Typhoid Fever; Salmonella Typhi Infection |
Sheikh Zayed Medical College |
2025-05-14 | PHASE4 |
| NCT04235816 | ACTIVE_NOT_RECRUITING | Child Mortality |
Barcelona Institute for Global Health |
2021-03-15 | PHASE3 |
| NCT05677282 | RECRUITING | Diarrhoea;Acute; Diarrhea Travelers |
Henry M. Jackson Foundation for the Advancement of Military Medicine |
2022-10-28 | PHASE4 |
| NCT06958146 | NOT_YET_RECRUITING | Maternal and Neonatal Sepsis; Intrapartum Antibiotics |
Armed Forces Hospital, Pakistan |
2025-05-01 | PHASE4 |
| NCT05972772 | RECRUITING | Infectious Disease; Therapeutics |
Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit |
2024-11-01 | PHASE2; PHASE3 |
| NCT06077916 | COMPLETED | Upper Gastrointestinal Bleeding |
Clinical Hospital Colentina |
2023-10-01 | |
| NCT07320612 | COMPLETED | Nephrotic Syndrome |
University of Child Health Sciences and Children's Hospital, Lahore |
2025-03-08 | PHASE1 |
| NCT07148622 | COMPLETED | Preterm Premature Rupture of Membranes (PPROM); Prophylaxis; Perinatal Outcomes |
Yuzuncu Yil University |
2024-10-01 | |
| NCT06584474 | COMPLETED | Bronchopulmonary Dysplasia; Premature; Ventilation, Mechanical |
Alexandria University |
2024-10-02 | PHASE4 |
| NCT04326478 | COMPLETED | Cholera |
Massachusetts General Hospital |
2021-10-31 | PHASE2 |
| NCT05328817 | UNKNOWN | Preterm Premature Rupture of Membrane |
Eastern Virginia Medical School |
2022-05-01 | |
| NCT07394725 | COMPLETED | Pre-term Premature Rupture of Membranes |
District Headquarters Teaching Hospital Sahiwal |
2024-04-01 | PHASE1 |
| NCT05121974 | COMPLETED | Shigellosis |
International Centre for Diarrhoeal Disease Research, Bangladesh |
2022-08-18 | PHASE2 |
| NCT03909737 | ACTIVE_NOT_RECRUITING | Stillbirths and Infant Mortality |
University of Maryland, Baltimore |
2020-09-24 | PHASE4 |
| NCT04716712 | ACTIVE_NOT_RECRUITING | Child Mortality |
University of California, San Francisco |
2021-10-04 | PHASE4 |
| NCT02754583 | COMPLETED | Trachoma |
University of California, San Francisco |
2015-12-05 | PHASE3 |
| NCT04424511 | COMPLETED | Mortality |
Tampere University |
2020-10-15 | PHASE3 |
| NCT04185402 | COMPLETED | Trachoma |
University of California, San Francisco |
2021-05-29 | PHASE4 |
| NCT04669288 | TERMINATED | Asthma; Wheezing |
University of Arizona |
2021-11-22 | PHASE3 |
| NCT05132829 | UNKNOWN | Preterm Birth; Obstetric Labor, Premature; Obstetric Labor Complications; Pregnancy Complications; Physiological Effects of Drugs; Uterine Cervical Incompetence; Anti-Bacterial Agents; Azithromycin; Cefazolin |
Thomas Jefferson University |
2021-12-20 | PHASE4 |
| NCT04481555 | COMPLETED | COPD; Inhaled Corticosteroid; Azithromycin; COPD Exacerbation; Pneumonia |
Chronic Obstructive Pulmonary Disease Trial Network, Denmark |
2021-06-28 | PHASE4 |
| NCT06272370 | COMPLETED | Asthma; Bronchial Diseases; Respiratory Tract Infections; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Immune System Diseases |
DARTNet Institute |
2024-02-01 | PHASE4 |
| NCT04224987 | COMPLETED | Mortality; Resistance Bacterial; Child, Only |
University of California, San Francisco |
2020-11-24 | PHASE4 |
| NCT05016895 | COMPLETED | Child Mortality |
FHI 360 |
2021-08-27 | |
| NCT04294641 | COMPLETED | Chronic GVHD |
National Cancer Institute (NCI) |
2021-05-10 | PHASE2 |
| NCT05764876 | COMPLETED | Yaws; Cutaneous Ulcer |
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia |
2023-03-14 | PHASE3 |
| NCT07064278 | COMPLETED | Refractory Mycoplasma Pneumoniae Pneumonia |
Children's Hospital of Hebei Province |
2022-12-01 | |
| NCT05596721 | UNKNOWN | Asthma; Chest Syndrome; Azithromycin; Effect of Drug |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2023-01-01 | PHASE4 |
| NCT03862495 | COMPLETED | Chlamydia Trachomatis Infection |
University of North Carolina, Chapel Hill |
2020-05-21 | |
| NCT05972772 | Not yet recruiting | Infectious Disease|Therapeutics |
Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit|Mahidol Oxford Tropical Medicine Research Unit |
2024-03-20 | Phase 2|Phase 3 |
| NCT05345457 | TERMINATED | Pregnancy Preterm; Pregnancy Prom; PROM, Preterm (Pregnancy); PROM (Pregnancy); Premat Rupture Membranes Preterm Unspec to Length of Time Between Rupture/Labor; Premature Birth |
University Hospitals Cleveland Medical Center |
2023-01-13 | PHASE4 |
| NCT05966688 | COMPLETED | Healthy Volunteers |
Spero Therapeutics |
2023-08-04 | PHASE1 |
| NCT05288023 | TERMINATED | Resistance Bacterial; Morality; Child Health; Implementation |
University of California, San Francisco |
2022-12-01 | PHASE4 |
| NCT04186247 | TERMINATED | Crohn Disease; Pediatric Crohns Disease |
University of North Carolina, Chapel Hill |
2021-08-13 | PHASE2 |
| NCT03060473 | TERMINATED | Preterm Premature Rupture of Membranes (PPROM) |
The University of Texas Medical Branch, Galveston |
2017-02-23 | PHASE3 |
| NCT04280406 | UNKNOWN | Dental Implant Failed |
Université de Montréal |
2020-02-25 | PHASE1 |
| NCT03676764 | COMPLETED | Childhood Mortality |
University of California, San Francisco |
2019-08-01 | PHASE4 |
| NCT05473234 | TERMINATED | Severe Acute Malnutrition |
University of California, San Francisco |
2022-10-06 | PHASE3 |
| NCT04198649 | TERMINATED | Severe Chronic Periodontitis |
University Hospital, Strasbourg, France |
2021-11-02 | PHASE3 |
| NCT04010539 | COMPLETED | Gonorrhea |
GlaxoSmithKline |
2019-10-21 | PHASE3 |
| NCT05971654 | UNKNOWN | Preterm Labor |
Beni-Suef University |
2023-07-30 | PHASE2; PHASE3 |
| NCT05634759 | COMPLETED | Trachoma |
Emory University |
2022-05-04 | PHASE4 |
| NCT04774991 | COMPLETED | Mortality; Child Health; Implementation |
University of California, San Francisco |
2021-06-28 | PHASE4 |
| NCT04353661 | TERMINATED | Chronic Obstructive Pulmonary Disease |
Genentech, Inc. |
2021-11-16 | PHASE2 |
| NCT04677543 | COMPLETED | Mycobacterium Infections, Nontuberculous |
Insmed Incorporated |
2020-12-22 | PHASE3 |
| NCT06149117 | COMPLETED | Upper Respiratory Tract Infection; Lower Respiratory Infection; Skin Infection; Subcutaneous Tissues Infection; Genital Infection |
Peking University People's Hospital |
2022-11-16 | PHASE4 |
| NCT05796362 | Not yet recruiting | Infectious Disease|Drug Effect|Clinical Infection |
Brigham and Women''s Hospital|Bill and Melinda Gates Foundation |
2023-04 | Phase 1 |
| NCT06199440 | COMPLETED | Periodontal Diseases; Type 2 Diabetes |
King Abdulaziz University |
2022-06-01 | PHASE1; PHASE2 |
| NCT03911440 | UNKNOWN | Atypical Pneumonia |
National Taiwan University Hospital |
2018-11-10 | |
| NCT03871491 | COMPLETED | Maternal Death; Maternal Infections Affecting Fetus or Newborn; Neonatal SEPSIS; Maternal Sepsis During Labor; Neonatal Death; Postpartum Sepsis |
NICHD Global Network for Women's and Children's Health |
2020-09-01 | PHASE3 |
| NCT03162497 | COMPLETED | Dry Eye Syndromes; Meibomian Gland Dysfunction |
Medical University of Vienna |
2018-01-08 | PHASE4 |
| NCT04012177 | UNKNOWN | Undernutrition |
Vital Pakistan Trust |
2019-07-22 | |
| NCT05437783 | UNKNOWN | Comparative Bioavailability Study |
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
2020-01-01 | PHASE1 |
| NCT05629468 | COMPLETED | Acne Vulgaris |
Pak Emirates Military Hospital |
2021-10-15 | PHASE3 |
| NCT06090565 | COMPLETED | Gonorrhea |
Bulovka Hospital |
2021-04-01 | PHASE4 |
| NCT03925480 | COMPLETED | Bacterial Infections |
Murdoch Childrens Research Institute |
2019-07-01 | PHASE3 |
| NCT03160638 | COMPLETED | Tuberculosis, Pulmonary |
University Medical Center Groningen |
2018-02-01 | PHASE2 |
| NCT05027516 | COMPLETED | Neisseria Gonorrhoeae |
Institute of Tropical Medicine, Belgium |
2022-01-17 | PHASE4 |
| NCT03682653 | COMPLETED | Childhood Mortality |
University of California, San Francisco |
2019-04-11 | PHASE4 |
| NCT04359953 | TERMINATED | COVID-19 Infection |
University Hospital, Strasbourg, France |
2020-04-25 | PHASE3 |
| NCT04341207 | UNKNOWN | Cancer & COVID 19 |
Gustave Roussy, Cancer Campus, Grand Paris |
2020-04-03 | PHASE2 |
| NCT04319705 | UNKNOWN | Asthma; COPD; Exacerbation Copd; Asthma; Eosinophilic; Bronchial Diseases; Lung Diseases, Obstructive; Lung Diseases; Immune System Diseases |
Bispebjerg Hospital |
2020-03-02 | PHASE4 |
| NCT04390152 | TERMINATED | Acute Respiratory Distress Syndrome |
BioXcellerator |
2020-01-13 | PHASE1; PHASE2 |
| NCT05311228 | COMPLETED | Bronchopulmonary Dysplasia; Intraventricular Hemorrhage; Necrotizing Enterocolitis |
Indonesia University |
2021-06-08 | PHASE4 |
| NCT03570814 | COMPLETED | Trachoma; Lymphatic Filariases |
London School of Hygiene and Tropical Medicine |
2021-12-01 | PHASE4 |
| NCT04454151 | UNKNOWN | Familial Adenomatous Polyposis |
Tel-Aviv Sourasky Medical Center |
2020-08-01 | PHASE4 |
| NCT03530319 | UNKNOWN | Pneumonia, Mycoplasma |
National Taiwan University Hospital |
2018-11-10 | |
| NCT04590274 | WITHDRAWN | Covid19; SARS (Severe Acute Respiratory Syndrome) |
International Brain Research Foundation |
2020-11 | PHASE1 |
| NCT04613271 | COMPLETED | Infectious Disease; SARS-CoV Infection; Covid19 |
Ina-Respond |
2020-10-15 | PHASE3 |
| NCT04954040 | UNKNOWN | Acute Respiratory Distress Syndrome; Covid19 |
Maimónides Biomedical Research Institute of Córdoba |
2021-02-10 | PHASE2 |
| NCT04395768 | UNKNOWN | COVID19 |
National Institute of Integrative Medicine, Australia |
2020-09-09 | PHASE2 |
| NCT04380818 | UNKNOWN | Pneumonia, Viral |
Grupo de Investigación Clínica en Oncología Radioterapia |
2020-06-05 | |
| NCT05026801 | WITHDRAWN | Respiratory Tract Infection Viral |
Iterum Therapeutics, International Limited |
2021-02-08 | PHASE3 |
| NCT03090048 | UNKNOWN | Acne Vulgaris |
Manchanda Medical Clinic |
2021-04-01 | EARLY_PHASE1 |
| NCT04296383 | UNKNOWN | Mycoplasma Pneumoniae Pneumonia |
Jiangxi Qingfeng Pharmaceutical Co. Ltd. |
2020-06-15 | |
| NCT04964583 | UNKNOWN | Covid19 |
Coordinación de Investigación en Salud, Mexico |
2021-01-20 | PHASE2; PHASE3 |
| NCT03953118 | TERMINATED | Dry Eye; Neuropathic Eye Pain; Ocular Microbiome; Depression, Anxiety |
University of California, San Francisco |
2019-09-01 | PHASE4 |
| NCT04459702 | WITHDRAWN | COVID; COVID-19; Corona Virus Infection; Coronavirus Infection; Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere; Coronavirus-19; SARS-CoV 2; SARS Pneumonia |
ProgenaBiome |
2020-07 | PHASE2 |
| NCT04369365 | COMPLETED | COVID |
Prof. Dr. Matthias Preusser |
2020-04-27 | PHASE2 |
| NCT04332094 | UNKNOWN | COVID-19 |
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau |
2020-04-02 | PHASE2 |
| NCT03840057 | UNKNOWN | Gastro Intestinal Bleeding; Upper Gastrointestinal Bleeding |
Waihong Chung |
2020-07-01 | PHASE2 |
| NCT03199547 | COMPLETED | Neonatal SEPSIS |
London School of Hygiene and Tropical Medicine |
2017-10-21 | PHASE3 |
| NCT05118984 | COMPLETED | Meconium Stained; Azithromycin; Postpartum Endometritis |
Cairo University |
2021-02-16 | PHASE4 |
| NCT04715295 | UNKNOWN | COVID-19 |
Yaounde Central Hospital |
2020-10-05 | PHASE4 |
| NCT04171388 | WITHDRAWN | Low Birthweight; Preterm Birth; Maternal; Malnutrition, Affecting Fetus; Sexually Transmitted Diseases; Urinary Tract Infections; Pregnancy and Infectious Disease |
Brigham and Women's Hospital |
2020-03-01 | PHASE4 |
| NCT04344444 | TERMINATED | COVID-19 |
LCMC Health |
2020-04-13 | PHASE3 |
| NCT04341727 | TERMINATED | Coronavirus Infection |
Washington University School of Medicine |
2020-04-04 | PHASE3 |
| NCT02336516 | COMPLETED | Haemolytic and Uremic Syndrome |
Assistance Publique - Hôpitaux de Paris |
2015-07 | |
| NCT02911935 | COMPLETED | Respiratory Syncytial Virus, Bronchiolitis |
Washington University School of Medicine |
2016-11 | PHASE2; PHASE3 |
| NCT04332107 | TERMINATED | COVID-19; SARS-CoV-2 |
Thomas M. Lietman |
2020-05-22 | PHASE3 |
| NCT03736629 | TERMINATED | Asthma Chronic |
University of Chicago |
2019-02-01 | PHASE2 |
| NCT04363203 | SUSPENDED | SARS-CoV-2; COVID-19 |
Salomeh Keyhani MD |
2020-04-30 | PHASE3 |
| NCT04673214 | COMPLETED | Covid19 |
Gilberto Cruz Arteaga |
2020-12-16 | PHASE3 |
| NCT04345861 | TERMINATED | Coronavirus Infection; Pneumonia, Viral |
University Hospital, Montpellier |
2020-04-11 | PHASE2; PHASE3 |
| NCT03854929 | COMPLETED | Dysentery, Shigella; Shigellosis; Diarrhea |
Oxford University Clinical Research Unit, Vietnam |
2019-12-11 | PHASE4 |
| NCT04322396 | TERMINATED | Virus Diseases; Infection Viral; Corona Virus Infection |
Chronic Obstructive Pulmonary Disease Trial Network, Denmark |
2020-04-06 | PHASE2 |
| NCT03751514 | UNKNOWN | Whooping Cough |
University of Southampton |
2017-05-22 | |
| NCT04617626 | COMPLETED | Child Mortality; Azithromycin |
FHI 360 |
2020-11-20 | |
| NCT04381962 | COMPLETED | COVID-19 |
University of Oxford |
2020-06-03 | PHASE3 |
| NCT03431168 | COMPLETED | HIV; Pregnancy Malaria; Sexually Transmitted Infection |
University of Alabama at Birmingham |
2018-03-07 | PHASE2 |
| NCT04202380 | COMPLETED | Preterm Pre-labor Rupture of Membranes |
Assiut University |
2020-01-01 | |
| NCT04394182 | SUSPENDED | Pneumonia, Viral; Cytokine Storm |
Fundacion GenesisCare |
2020-04-21 | |
| NCT04411433 | UNKNOWN | Sars-CoV2; COVID-19 |
Ministry of Health, Turkey |
2020-05-08 | PHASE3 |
| NCT04334382 | UNKNOWN | COVID-19 |
Intermountain Health Care, Inc. |
2020-04-02 | PHASE3 |
| NCT04365582 | WITHDRAWN | COVID |
Fondation Hôpital Saint-Joseph |
2020-05-07 | PHASE3 |
| NCT04154722 | COMPLETED | Typhoid Fever |
Ziauddin University |
2019-06-20 | PHASE4 |
| NCT04294069 | COMPLETED | Preterm Premature Rupture of Membrane |
Thomas Jefferson University |
2020-09-14 | PHASE4 |
| NCT03568643 | COMPLETED | Uncomplicated Severe Acute Malnutrition |
University of California, San Francisco |
2020-06-03 | PHASE3 |
| NCT04405921 | UNKNOWN | SARS-CoV-2 Pneumonia; COVID-19 |
Centre Hôpital Universitaire Farhat Hached |
2020-07 | PHASE3 |
| NCT03618108 | TERMINATED | Coronary Heart Disease; Chlamydophila Pneumoniae Infections |
Cadrock Pty. Ltd. |
2018-04-04 | PHASE2 |
| NCT03564652 | COMPLETED | Undernutrition |
Vital Pakistan Trust |
2018-08-01 | |
| NCT04338698 | COMPLETED | COVID 19 |
Shehnoor Azhar |
2020-04-22 | PHASE3 |
| NCT04361461 | WITHDRAWN | Coronavirus Infections; SARS-CoV 2; SARS (Severe Acute Respiratory Syndrome); Pulmonary Disease |
Apsen Farmaceutica S.A. |
2020-04-30 | PHASE3 |
| NCT04354428 | TERMINATED | COVID-19; SARS-CoV-2 |
University of Washington |
2020-04-16 | PHASE2; PHASE3 |
| NCT04347031 | COMPLETED | Pneumonia, Viral; Respiratory Failure |
Burnasyan Federal Medical Biophysical Center |
2020-04-08 | PHASE2; PHASE3 |
| NCT04374552 | WITHDRAWN | SARS-CoV-2 Infection |
Rutgers, The State University of New Jersey |
2020-05-05 | PHASE2 |
| NCT04336332 | TERMINATED | SARS-CoV-2; COVID-19 |
Rutgers, The State University of New Jersey |
2020-04-01 | PHASE2 |
| NCT04355052 | UNKNOWN | COVID - 19 |
Sheba Medical Center |
2020-04-11 | PHASE3 |
| NCT04370782 | COMPLETED | COVID-19 |
St. Francis Hospital, New York |
2020-04-28 | PHASE4 |
| NCT04729491 | COMPLETED | Covid19 |
Corpometria Institute |
2020-06-30 | PHASE2; PHASE3 |
| NCT04349410 | COMPLETED | CoVid 19 Positive |
The Camelot Foundation |
2020-04-11 | PHASE2; PHASE3 |
| NCT04392128 | WITHDRAWN | COVID19; Hematologic Malignancy |
Institut de cancérologie Strasbourg Europe |
2020-09-02 | PHASE2 |
| NCT04575558 | WITHDRAWN | Sars-CoV2 |
Latin American Cooperative Oncology Group |
2020-06-30 | PHASE2 |
| NCT04501965 | UNKNOWN | Covid19 |
Institute for Research and Development of Medicinal and Food Plants of Guinea |
2020-06-01 | PHASE2 |
| NCT04383717 | UNKNOWN | Respiratory Tract Infections |
Cairo University |
2020-05-05 | PHASE3 |
| NCT02048007 | COMPLETED | Childhood Mortality |
University of California, San Francisco |
2014-11 | PHASE4 |
| NCT03532464 | COMPLETED | Chlamydia Trachomatis Infection; Vaginal Infection; Anal Infection |
University Hospital, Bordeaux |
2018-10-10 | PHASE4 |
| NCT04354597 | WITHDRAWN | COVID-19 |
King Hussein Cancer Center |
2020-05-01 | |
| NCT04349592 | COMPLETED | Covid19 |
Hamad Medical Corporation |
2020-04-14 | |
| NCT04371406 | WITHDRAWN | Covid-19 |
Assistance Publique - Hôpitaux de Paris |
2020-04 | PHASE3 |
| NCT04457609 | UNKNOWN | COVID; Pulmonary Infection; Sars-CoV2 |
Indonesia University |
2020-07 | PHASE1 |
| NCT04160026 | COMPLETED | Malaria in Pregnancy; Adherence, Treatment |
Liverpool School of Tropical Medicine |
2019-11-11 | PHASE4 |
| NCT03338244 | COMPLETED | Childhood Mortality |
University of California, San Francisco |
2017-10-20 | PHASE4 |
| NCT04622891 | COMPLETED | Covid19 |
South Valley University |
2020-04-01 | |
| NCT04363060 | UNKNOWN | COVID-19 Pneumonia |
Nantes University Hospital |
2020-04-30 | PHASE3 |
| NCT04358081 | COMPLETED | Covid-19 |
Novartis Pharmaceuticals |
2020-05-01 | PHASE3 |
| NCT04351919 | WITHDRAWN | Patients With COVID19 |
Abderrahmane Mami Hospital |
2020-05-05 | PHASE4 |
| NCT04528927 | WITHDRAWN | COVID 19; Patients Hospitalized |
Abderrahmane Mami Hospital |
2020-05-15 | PHASE3 |
| NCT04358068 | TERMINATED | COVID-19; SARS-CoV 2 |
National Institute of Allergy and Infectious Diseases (NIAID) |
2020-05-13 | PHASE2 |
| NCT03676751 | COMPLETED | Child Growth; Diversity of Microbiome; Child Mortality; Resistance Bacterial |
University of California, San Francisco |
2019-10-10 | PHASE4 |
| NCT04329832 | COMPLETED | COVID-19 |
Intermountain Health Care, Inc. |
2020-03-30 | PHASE2 |
| NCT04348474 | SUSPENDED | Covid-19 |
Azidus Brasil |
2020-04-20 | EARLY_PHASE1 |
| NCT04020380 | COMPLETED | Sarcoidosis, Pulmonary |
Hull University Teaching Hospitals NHS Trust |
2019-09-06 | PHASE2 |
| NCT04344379 | COMPLETED | SARS-CoV-2 Infection |
Assistance Publique - Hôpitaux de Paris |
2020-04-17 | PHASE3 |
| NCT04335552 | TERMINATED | SARS-CoV-2 |
Duke University |
2020-04-17 | PHASE2 |
| NCT04321278 | COMPLETED | Coronavirus Infections; Pneumonia, Viral |
Hospital Israelita Albert Einstein |
2020-03-28 | PHASE3 |
| NCT04347512 | WITHDRAWN | Sars-CoV-2, Community-Acquired Pneumonia,COVID-19 |
University Hospital, Strasbourg, France |
2020-06-02 | PHASE3 |
| NCT04322123 | COMPLETED | Coronavirus Infections |
Hospital do Coracao |
2020-04-01 | PHASE3 |
| NCT04371107 | SUSPENDED | Covid19; Azithromycin; Ambulatory |
Centre Hospitalier Universitaire, Amiens |
2020-04-29 | PHASE3 |
| NCT04365231 | WITHDRAWN | COVID19 |
Hospital St. Joseph, Marseille, France |
2020-04-01 | PHASE3 |
| NCT03165123 | UNKNOWN | Post-operative Nausea and Vomiting |
Assiut University |
2019-06-01 | PHASE4 |
| NCT03831269 | UNKNOWN | Pityriasis Lichenoides |
Cairo University |
2019-02 | |
| NCT04329572 | SUSPENDED | COVID-19 |
Azidus Brasil |
2020-04-23 | EARLY_PHASE1 |
| NCT04328272 | UNKNOWN | COVID19 |
Prof. Dr. Umar Farooq |
2020-03-28 | PHASE3 |
| NCT04399746 | COMPLETED | COVID |
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado |
2020-03-15 | |
| NCT03248297 | COMPLETED | Postpartum Sepsis; Postpartum Endometritis; Postpartum Fever |
University of Alabama at Birmingham |
2018-01-12 | PHASE4 |
| NCT04341870 | SUSPENDED | COVID19; SARS-CoV-2 Infection |
Assistance Publique - Hôpitaux de Paris |
2020-04-11 | PHASE2; PHASE3 |
| NCT02414399 | UNKNOWN | Pneumonia; Diarrhea; Malaria; Co-infection; Death; Malnutrition |
University of Washington |
2016-06-28 | PHASE4 |
| NCT04359316 | UNKNOWN | COVID-19 |
Shahid Beheshti University of Medical Sciences |
2020-04-20 | PHASE4 |
| NCT03490123 | COMPLETED | Yaws |
Lihir Medical Centre |
2018-04-16 | PHASE4 |
| NCT03341273 | TERMINATED | Lower Respiratory Tract Infection |
National Institute of Allergy and Infectious Diseases (NIAID) |
2017-12-08 | |
| NCT03683667 | COMPLETED | Stunting; Malnutrition; Protein; Enteric Pathogens; Campylobacter Infections |
Johns Hopkins Bloomberg School of Public Health |
2018-09-23 | PHASE2; PHASE3 |
| NCT03208179 | COMPLETED | Pregnancy; Malaria in Pregnancy; Malaria |
Liverpool School of Tropical Medicine |
2018-03-29 | PHASE3 |
| NCT03545373 | COMPLETED | Tuberculosis; Respiratory Tract Infections; Pneumonia |
London School of Hygiene and Tropical Medicine |
2019-02-25 | PHASE3 |
| NCT01270074 | COMPLETED | Cystic Fibrosis; Bronchiectasis |
The University of Queensland |
2012-04 | PHASE3 |
| NCT03268902 | COMPLETED | Malnutrition; Stunting; Cognitive Development; Enteric Pathogens |
Haydom Lutheran Hospital |
2017-09-05 | PHASE2; PHASE3 |
| NCT04278937 | COMPLETED | Preterm Birth |
Ain Shams Maternity Hospital |
2019-04-15 | PHASE4 |
| NCT02677701 | COMPLETED | Cystic Fibrosis |
Seattle Children's Hospital |
2016-10-21 | PHASE4 |
| NCT03130114 | COMPLETED | Diarrhea |
World Health Organization |
2017-05-13 | PHASE3 |
| NCT03944317 | UNKNOWN | Malaria in Pregnancy; Pregnancy |
Federal Medical Centre, Owo |
2019-06-01 | |
| NCT04179461 | COMPLETED | Asthma in Children |
Children's Hospital Medical Center, Cincinnati |
2018-03-16 | PHASE2 |
| NCT03960970 | UNKNOWN | Endometritis; Cesarean Section; Infection; Wound Infection |
RWJ Barnabas Health at Jersey City Medical Center |
2019-09-15 | PHASE2 |
| NCT03079388 | COMPLETED | Pregnancy; Malnutrition in Pregnancy; Nutrition Disorders; Stunting |
Washington University School of Medicine |
2017-02-27 | |
| NCT02173145 | COMPLETED | Idiopathic Pulmonary Fibrosis; Cough |
Insel Gruppe AG, University Hospital Bern |
2014-08-19 | |
| NCT04062175 | COMPLETED | Wound Sepsis |
Ain Shams University |
2019-03-20 | PHASE4 |
| NCT02024555 | COMPLETED | Sarcoidosis; Antimycobacterial Therapy |
Vanderbilt University |
2014-03 | PHASE2 |
| NCT03578679 | COMPLETED | Pediculoses |
Institut de Recherche pour le Developpement |
2018-07-11 | |
| NCT02913118 | UNKNOWN | Community Acquired Pneumonia |
Qingfeng Pharmaceutical Group |
2016-07 | PHASE4 |
| NCT02972957 | COMPLETED | Influenza |
London School of Hygiene and Tropical Medicine |
2017-01-30 | PHASE4 |
| NCT03676140 | COMPLETED | Trachoma; Yaws; Lymphatic Filariases; Scabies; Strongyloidiasis |
Lihir Medical Centre |
2018-10-01 | PHASE3 |
| NCT03045198 | UNKNOWN | Cystic Fibrosis |
University Childrens' Hospital (Zentrum für Kinderheilkunde des Universitätsklinikum Bonn) |
2012-03 | PHASE4 |
| NCT02557958 | COMPLETED | Chronic Obstructive Pulmonary Disease |
NYU Langone Health |
2009-01 | EARLY_PHASE1 |
| NCT01224977 | UNKNOWN | Asthmatic Patients |
Universitaire Ziekenhuizen KU Leuven |
2011-07 | |
| NCT03664063 | COMPLETED | Lymphatic Filariasis; Yaws; Trauma |
Lihir Medical Centre |
2018-09-01 | PHASE2 |
| NCT02960503 | WITHDRAWN | Sickle Cell Disease |
Vanderbilt University |
2016-09 | PHASE1; PHASE2 |
| NCT02047981 | COMPLETED | Childhood Mortality |
University of California, San Francisco |
2014-12 | PHASE4 |
| NCT02426112 | COMPLETED | Chronic Lung Disease; HIV Infection |
London School of Hygiene and Tropical Medicine |
2016-06 | PHASE3 |
| NCT02054156 | COMPLETED | Cystic Fibrosis |
Bonnie Ramsey |
2014-06 | PHASE3 |
| NCT03233880 | UNKNOWN | Pre-Eclampsia |
Ain Shams Maternity Hospital |
2016-07-01 | PHASE4 |
| NCT03502356 | UNKNOWN | Randomized Controll Trial |
Ain Shams University |
2018-04-20 | PHASE1; PHASE2 |
| NCT02003911 | TERMINATED | Asthma |
Montefiore Medical Center |
2013-10 | PHASE4 |
| NCT02205255 | COMPLETED | Chronic Obstructive Pulmonary Disease |
Wim Janssens |
2014-08-01 | PHASE3 |
| NCT03353480 | COMPLETED | Bioequivalence |
Pfizer |
2017-12-20 | PHASE1 |
| NCT02211729 | COMPLETED | Malaria; Respiratory Infections |
London School of Hygiene and Tropical Medicine |
2014-05 | PHASE3 |
| NCT02630394 | WITHDRAWN | Sickle Cell Disease; Acute Chest Syndrome |
University of Mississippi Medical Center |
2015-09 | PHASE1 |
| NCT03273296 | COMPLETED | Microbial Colonization |
Finnish Institute for Health and Welfare |
2017-10-15 | PHASE4 |
| NCT02830230 | UNKNOWN | Cervical Inflammation and Human Papilloma Virus Performance |
Tata Memorial Hospital |
2016-07 | |
| NCT03252067 | UNKNOWN | Pharmacokinetics |
Beijing Tongren Hospital |
2017-08-02 | PHASE1 |
| NCT03235141 | UNKNOWN | Bacterial Conjunctivitis |
Beijing Tongren Hospital |
2017-07-07 | PHASE1 |
| NCT02135354 | TERMINATED | Chronic Obstructive Pulmonary Disease |
Wim Janssens |
2014-08-01 | PHASE3 |
| NCT03187834 | COMPLETED | Child Development |
University of California, San Francisco |
2017-07-04 | PHASE4 |
| NCT02307825 | COMPLETED | Chronic Rhinosinusitis; High-risk Patient |
Centre hospitalier de l'Université de Montréal (CHUM) |
2014-11 | PHASE4 |
| NCT02756403 | COMPLETED | First Trimester Abortion |
Medstar Health Research Institute |
2016-03 | |
| NCT01955252 | COMPLETED | Yaws |
Lihir Medical Centre |
2013-03 | PHASE3 |
| NCT01959100 | UNKNOWN | Malignant Hematological Diseases |
Assistance Publique - Hôpitaux de Paris |
2014-02 | PHASE3 |
| NCT02544984 | COMPLETED | Chronic Lung Disease |
The University of Texas Health Science Center, Houston |
2015-10 | |
| NCT02210325 | COMPLETED | Uncomplicated Urogenital Gonorrhea |
Melinta Therapeutics, Inc. |
2014-08 | PHASE3 |
| NCT03032042 | WITHDRAWN | Helminth Infection |
University of California, San Francisco |
2017-01 | PHASE4 |
| NCT02282176 | WITHDRAWN | Bronchopulmonary Dysplasia |
Institut National de la Santé Et de la Recherche Médicale, France |
2015-01 | PHASE3 |
| NCT02708992 | COMPLETED | Gonorrhoea |
National Institute of Allergy and Infectious Diseases (NIAID) |
2016-04-28 | PHASE1 |
| NCT02344628 | COMPLETED | Yaws |
London School of Hygiene and Tropical Medicine |
2015-06 | PHASE3 |
| NCT02622802 | COMPLETED | Pregnancy |
University Hospital, Gasthuisberg |
2012-11 | |
| NCT02196493 | UNKNOWN | Chronic Cough |
University of Nottingham |
2013-12 | PHASE3 |
| NCT01778634 | COMPLETED | Ureaplasma Infections |
University of Maryland, Baltimore |
2013-07 | PHASE2 |
| NCT02926326 | COMPLETED | Interaction |
Mereo BioPharma |
2016-09 | PHASE1 |
| NCT03629288 | COMPLETED | Periodontitis |
Universidad Nacional Andres Bello |
2016-03-01 | |
| NCT02527005 | COMPLETED | Malaria; Pregnant; HIV |
University of Ibadan |
2015-09 | PHASE1 |
| NCT02372383 | COMPLETED | Cystic Fibrosis |
University of Colorado, Denver |
2014-10 | |
| NCT03485703 | COMPLETED | Bronchopulmonary Dysplasia |
Hospital de Clinicas de Porto Alegre |
2012-08-28 | PHASE4 |
| NCT01618591 | TERMINATED | Acute Watery Diarrhea; Dysentery/Febrile Diarrhea |
Uniformed Services University of the Health Sciences |
2012-09 | |
| NCT02600806 | UNKNOWN | Community-acquired Pneumonia |
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana |
2005-05 | PHASE4 |
| NCT01825031 | COMPLETED | Human Immunodeficiency Virus |
Anna Griffiths, MRC |
2013-06 | PHASE3 |
| NCT02380625 | UNKNOWN | Ebola Virus Disease |
Clinical Research Management, Inc. |
2015-04 | PHASE1; PHASE2 |
| NCT02491723 | COMPLETED | Bronchiectasis |
Jin-Fu Xu |
2014-01 | |
| NCT01596894 | COMPLETED | Crohn's Disease |
Prof. Arie Levine |
2012-10 | PHASE4 |
| NCT01235546 | COMPLETED | Endometritis; Wound Infection; Abscess; Surgical Site Infection |
Alan Tita |
2011-05 | |
| NCT00944515 | COMPLETED | Sinusitis |
Mahidol University |
2009-08 | |
| NCT01767506 | COMPLETED | Trachoma |
Johns Hopkins University |
2013-01 | |
| NCT01919996 | TERMINATED | Pharyngitis; Tonsillitis |
Pfizer |
2013-12 | PHASE2 |
| NCT02362906 | UNKNOWN | Pneumonia |
Liaoning University of Traditional Chinese Medicine |
2014-04 | |
| NCT01661985 | UNKNOWN | Urethritis; Cervicitis; Genital Mycoplasma Infection; Chlamydia Trachomatis |
Ostergotland County Council, Sweden |
2010-02 | PHASE4 |
| NCT04870138 | COMPLETED | Gonococcal Infection |
National Institute of Allergy and Infectious Diseases (NIAID) |
2013-03-10 | PHASE1 |
| NCT01272635 | COMPLETED | Asthma; Wheezing |
Milton S. Hershey Medical Center |
2011-03 | PHASE3 |
| NCT01259141 | COMPLETED | Mycoplasma Pneumonia |
Capital Medical University |
2010-10 | |
| NCT01800942 | COMPLETED | Neonatal Infection |
London School of Hygiene and Tropical Medicine |
2013-02 | PHASE3 |
| NCT02224040 | UNKNOWN | Typhoid Fever |
Sheba Medical Center |
2013-08 | PHASE4 |
| NCT01617083 | COMPLETED | PANS; PANDAS; Obsessive Compulsive Disorder (OCD) |
University of South Florida |
2012-05 | PHASE2 |
| NCT01721616 | WITHDRAWN | Endometritis |
University of Missouri, Kansas City |
2012-11 | PHASE4 |
| NCT01307462 | COMPLETED | Bronchiolitis Obliterans |
Stephanie Lee |
2011-06 | PHASE2 |
| NCT02176057 | WITHDRAWN | Trachoma |
University of California, San Francisco |
2014-08 | PHASE2; PHASE3 |
| NCT02023554 | COMPLETED | Chronic Obstructive Pulmonary Disease; Asthma |
Zhujiang Hospital |
2013-12 | |
| NCT01444469 | COMPLETED | Asthma |
Imperial College London |
2011-09 | PHASE4 |
| NCT01825408 | COMPLETED | Sinusitis |
University of North Carolina, Chapel Hill |
2013-02 | PHASE4 |
| NCT00980148 | COMPLETED | Chlamydial Infection |
National Institute of Allergy and Infectious Diseases (NIAID) |
2009-12-02 | PHASE3 |
| NCT01486758 | COMPLETED | RSV Bronchiolitis |
Washington University School of Medicine |
2011-12 | PHASE2 |
| NCT02215460 | COMPLETED | Periodontitis |
University of Taubate |
2012-04 | PHASE4 |
| NCT01903057 | WITHDRAWN | Trachoma; Lymphatic Filariasis |
Emory University |
2014-02 | PHASE4 |
| NCT02126267 | COMPLETED | Periodontal Disease; Chronic Periodontitis |
Centro Universitario de Lavras |
2013-01 | |
| NCT01783340 | WITHDRAWN | Malaria, Falciparum |
Radboud University Medical Center |
2013-04 | PHASE1; PHASE2 |
| NCT01531218 | COMPLETED | Diarrhea; Fever; Vomiting; Abdominal Pain |
University of Aarhus |
2012-03 | PHASE3 |
| NCT00411736 | COMPLETED | Cystic Fibrosis |
Rigshospitalet, Denmark |
2008-05 | PHASE4 |
| NCT01769027 | WITHDRAWN | Pandas |
CNS Onlus |
2013-06 | PHASE2 |
| NCT02107274 | COMPLETED | Bronchiectasis |
Penang Hospital, Malaysia |
2011-11 | PHASE4 |
| NCT01202331 | COMPLETED | Trachoma; Chlamydia |
University of California, San Francisco |
2010-11 | PHASE4 |
| NCT00708799 | TERMINATED | Systemic Inflammatory Response Syndrome |
VA Office of Research and Development |
2007-11 | PHASE2 |
| NCT01103063 | TERMINATED | Intermittent Preventive Treatment In Pregnancy (IPTp) |
Pfizer |
2010-10 | PHASE3 |
| NCT01783860 | COMPLETED | Posterior Blepharitis |
Tehran University of Medical Sciences |
2013-01 | PHASE2 |
| NCT01876108 | COMPLETED | Fatty Liver; Liver Dysfunction; Insulin Resistance |
Tehran University of Medical Sciences |
2012-07 | PHASE2 |
| NCT01327625 | TERMINATED | Graft vs Host Disease; Bronchiolitis Obliterans |
Asan Medical Center |
2011-03 | |
| NCT01103713 | TERMINATED | Asymptomatic Parasitemia In Pregnancy |
Pfizer |
2011-03 | PHASE3 |
| NCT00792922 | COMPLETED | Trachoma |
Johns Hopkins University |
2008-05 | PHASE4 |
| NCT01721694 | WITHDRAWN | Ocular Inflammation; Infection Associated Blepharitis; Keratitis; Conjunctivitis, Bacterial |
Adapt Produtos Oftalmológicos Ltda. |
2012-12 | PHASE3 |
| NCT01921738 | COMPLETED | Chronic Periodontitis |
Isfahan University of Medical Sciences |
2012-05 | PHASE2 |
| NCT01398072 | UNKNOWN | Chronic Obstructive Pulmonary Disease (COPD). |
University College, London |
2011-12 | PHASE3 |
| NCT00926796 | COMPLETED | Gonorrhoea |
National Institute of Allergy and Infectious Diseases (NIAID) |
2010-06 | PHASE4 |
| NCT01323582 | TERMINATED | Gastroparesis |
University of Florida |
2009-02 | PHASE2 |
| NCT01560962 | TERMINATED | Blepharitis |
Southern California Institute for Research and Education |
2012-01 | |
| NCT01008761 | UNKNOWN | Asthma |
Janielee Williamson |
2010-01 | |
| NCT01432080 | TERMINATED | Respiratory Tract Infections; Bronchiolitis Obliterans; Cryptogenic Organizing Pneumonia; Lung Diseases, Interstitial |
Maisonneuve-Rosemont Hospital |
2011-09 | PHASE2 |
| NCT01374126 | COMPLETED | Falciparum Malaria |
Medical University of Vienna |
2011-07 | PHASE2 |
| NCT01556334 | WITHDRAWN | Preterm Premature Ruptured Membranes |
Indiana University |
2010-04 | PHASE3 |
| NCT01109160 | COMPLETED | Lymphocytic Bronchi(Oli)Tis Post-lung Transplantation |
KU Leuven |
2010-04 | PHASE4 |
| NCT01469702 | UNKNOWN | Cat-scratch Disease; Bartonella Infections |
Tel-Aviv Sourasky Medical Center |
2011-12 | PHASE4 |
| NCT00319956 | COMPLETED | Bronchopulmonary Dysplasia |
Hubert Ballard |
2004-09 | PHASE2 |
| NCT01089608 | COMPLETED | Blepharitis |
Laboratoires Thea |
2010-03 | PHASE2 |
| NCT01071161 | COMPLETED | Cough; Chronic Obstructive Pulmonary Disease; Chronic Bronchitis |
Isala |
2009-09 | PHASE3 |
| NCT00682656 | TERMINATED | Cutaneous Leishmaniasis |
Ana Rabello |
2008-06 | PHASE2; PHASE3 |
| NCT00358462 | COMPLETED | Urethritis |
University of Washington |
2007-01 | PHASE3 |
| NCT01667692 | COMPLETED | Peptic Ulcer; Dyspepsia; H-pylori |
Shahid Sadoughi University of Medical Sciences and Health Services |
2011-03 | PHASE4 |
| NCT01072136 | TERMINATED | Vaginitis Bacterial; Cervicitis |
National Institute of Allergy and Infectious Diseases (NIAID) |
2010-03 | PHASE3 |
| NCT01382004 | COMPLETED | Yaws; Treponema Infection; Neglected Tropical Disease |
Lihir Medical Centre |
2010-09 | PHASE3 |
| NCT01220258 | TERMINATED | Posterior Blepharoconjunctivitis |
Merck Sharp & Dohme LLC |
2010-11 | PHASE2 |
| NCT00852579 | COMPLETED | Asthma |
Euan J Cameron |
2009-03 | PHASE3 |
| NCT05299567 | COMPLETED | Bronchiolitis Obliterans |
Claudio Castanos |
2010-08-24 | PHASE4 |
| NCT01154569 | COMPLETED | Bariatric Surgery |
University of Alberta |
2010-06 | |
| NCT01269658 | TERMINATED | Blepharitis |
Merck Sharp & Dohme LLC |
2010-12 | PHASE2 |
| NCT01416350 | COMPLETED | Autoimmune Diseases |
GlaxoSmithKline |
2011-03-30 | PHASE1 |
| NCT00760838 | COMPLETED | Asthma |
University Hospital, Ghent |
2009-03 | PHASE4 |
| NCT01105624 | COMPLETED | Contact Lens Dry Eye |
Merck Sharp & Dohme LLC |
2010-03 | PHASE4 |
| NCT01243008 | COMPLETED | Lyme Disease |
University of Zurich |
2010-04 | PHASE1; PHASE2 |
| NCT01169038 | COMPLETED | Pulmonary Sarcoidosis; Lung Function |
Vanderbilt University |
2010-07 | PHASE1 |
| NCT00871494 | COMPLETED | Pelvic Inflammatory Disease |
Pfizer |
2009-05 | PHASE3 |
| NCT00677833 | COMPLETED | Malaria, Falciparum |
Pfizer |
2008-06 | PHASE2; PHASE3 |
| NCT00325897 | COMPLETED | Pulmonary Disease, Chronic Obstructive |
University of Minnesota |
2006-03 | |
| NCT01100060 | COMPLETED | Malaria Prophylaxis |
Pfizer |
2010-04 | PHASE1 |
| NCT01217099 | TERMINATED | Refractory Mycoplasma Pneumoniae Pneumonia |
Chongqing Medical University |
2007-05 | |
| NCT01014078 | COMPLETED | Dry Eye Disease |
Merck Sharp & Dohme LLC |
2009-10 | PHASE4 |
| NCT00809328 | COMPLETED | Community Acquired Pneumonia (CAP) |
Pfizer |
2009-02 | PHASE3 |
| NCT01586169 | COMPLETED | Parasitic Diseases; Bacterial Diseases |
Centre d'Appui à la lutte contre la Maladie |
2010-02 | |
| NCT00892970 | COMPLETED | Blepharitis |
Merck Sharp & Dohme LLC |
2009-04 | PHASE2 |
| NCT00415350 | COMPLETED | Bronchiectasis; Inflammation |
W.G.Boersma |
2008-04 | PHASE3 |
| NCT00894530 | COMPLETED | Blepharitis |
Merck Sharp & Dohme LLC |
2009-05 | PHASE2 |
| NCT01009619 | COMPLETED | Bronchiolitis Obliterans Syndrome; Graft Rejection; Lymphocytic Bronchiolitis; Respiratory Infection |
KU Leuven |
2005-09 | PHASE4 |
| NCT01026064 | COMPLETED | Inflammation |
GlaxoSmithKline |
2009-06-04 | PHASE1 |
| NCT00322972 | COMPLETED | Trachoma; Chlamydia |
University of California, San Francisco |
2006-06 | PHASE4 |
| NCT01348321 | COMPLETED | Acne |
Ahvaz Jundishapur University of Medical Sciences |
2008-11 | PHASE2; PHASE3 |
| NCT00379821 | COMPLETED | Plasmodium Falciparum Infection |
National Institute of Allergy and Infectious Diseases (NIAID) |
2007-02 | PHASE3 |
| NCT00879983 | COMPLETED | Healthy Volunteers |
Pfizer |
2009-05 | PHASE1 |
| NCT00599053 | TERMINATED | Bacteria Infection; Respiratory Tract Infections |
University of Alabama at Birmingham |
2007-05 | PHASE1; PHASE2 |
| NCT00618449 | COMPLETED | Trachoma; Chlamydia Trachomatis |
University of California, San Francisco |
2008-01 | PHASE4 |
| NCT00717561 | COMPLETED | Pneumonia |
Bayer |
2008-02 | PHASE3 |
| NCT00322465 | COMPLETED | Urethritis |
National Institute of Allergy and Infectious Diseases (NIAID) |
2006-11-17 | PHASE2 |
| NCT00844207 | COMPLETED | Malaria |
Pfizer |
2009-02 | PHASE1 |
| NCT00796224 | COMPLETED | Acute Otitis Media |
Pfizer |
2008-12 | PHASE2 |
| NCT00298922 | UNKNOWN | Cystic Fibrosis |
Unity Health Toronto |
2006-02 | PHASE2 |
| NCT00694694 | COMPLETED | Malaria |
London School of Hygiene and Tropical Medicine |
2008-06 | PHASE3 |
| NCT00575367 | COMPLETED | Bacterial Infections; Eye Infections |
Merck Sharp & Dohme LLC |
2008-03 | PHASE4 |
| NCT00741052 | COMPLETED | Cholera |
International Centre for Diarrhoeal Disease Research, Bangladesh |
2007-07 | PHASE3 |
| NCT00578955 | COMPLETED | Blepharoconjunctivitis |
Sun Pharmaceutical Industries Limited |
2007-12 | PHASE3 |
| NCT00351273 | COMPLETED | Arthritis, Reactive; Reiter Disease |
University of South Florida |
2006-05 | PHASE3 |
| NCT00254566 | COMPLETED | Chronic Bronchitis |
Pfizer |
2006-02 | PHASE3 |
| NCT00983294 | COMPLETED | Pharmacokinetics |
Mutual Pharmaceutical Company, Inc. |
2008-07 | PHASE1 |
| NCT00629941 | COMPLETED | Blepharitis |
Merck Sharp & Dohme LLC |
2008-03 | PHASE4 |
| NCT00524095 | TERMINATED | Bronchiectasis; Pulmonary Disease; Chronic Bronchitis |
University of Milan |
2006-09 | PHASE2 |
| NCT00392223 | TERMINATED | Acne Vulgaris |
Pfizer |
2007-10 | PHASE3 |
| NCT00575380 | COMPLETED | Bacterial Infections; Eye Infections; Cataract Extraction |
Merck Sharp & Dohme LLC |
2007-12 | PHASE4 |
| NCT00599079 | COMPLETED | Mycobacterium Avium Complex Lung Disease |
The University of Texas Health Science Center at Tyler |
1993-02 | PHASE4 |
| NCT00282919 | COMPLETED | Falciparum Malaria |
Pfizer |
2006-03 | PHASE2 |
| NCT00419848 | UNKNOWN | Acne |
Shahid Beheshti University of Medical Sciences |
2006-08 | PHASE2 |
| NCT00883818 | COMPLETED | Overactive Bladder |
Samsung Medical Center |
2007-01 | PHASE4 |
| NCT01178762 | COMPLETED | Chlamydial Conjunctivitis |
National Taiwan University Hospital |
2007-09 | |
| NCT00367653 | COMPLETED | Malaria |
Pfizer |
2006-11 | PHASE3 |
| NCT00356005 | COMPLETED | Uncomplicated Falciparum Malaria |
Medical University of Vienna |
2006-08 | PHASE2 |
| NCT00031499 | COMPLETED | Syphilis |
National Institute of Allergy and Infectious Diseases (NIAID) |
2000-06 | PHASE3 |
| NCT00286026 | WITHDRAWN | Trachoma |
University of California, San Francisco |
2005-06 | PHASE4 |
| NCT00360464 | COMPLETED | Acute Bronchitis |
Pfizer |
2006-10 | PHASE3 |
| NCT00131235 | ACTIVE_NOT_RECRUITING | Malaria; Sexually Transmitted Diseases; Preterm Birth; Pregnancy |
Tampere University |
2003-12 | PHASE3 |
| NCT00393835 | COMPLETED | Upper Respiratory Tract Infection |
Pfizer |
2006-11 | PHASE3 |
| NCT00360295 | COMPLETED | Pneumonia, Community-Acquired |
Pfizer |
2006-09 | PHASE3 |
| NCT01463371 | COMPLETED | Bronchiectasis |
Instituto de Investigacion Sanitaria La Fe |
2006-10 | |
| NCT00315601 | TERMINATED | Healthy |
University of Illinois at Chicago |
2006-01 | PHASE4 |
| NCT00598962 | COMPLETED | Mycobacterium Avium Complex |
The University of Texas Health Science Center at Tyler |
1994-12 | PHASE4 |
| NCT00132951 | TERMINATED | Respiratory Tract Infections; Chronic Bronchitis; Pneumonia |
Sanofi |
2004-10 | PHASE4 |
| NCT00237445 | TERMINATED | Pneumonia |
Sanofi |
2005-11 | PHASE4 |
| NCT00181272 | TERMINATED | Asthma; Chronic Obstructive Pulmonary Disease |
Johns Hopkins University |
2005-09 | PHASE2 |
| NCT00315003 | TERMINATED | Otitis Media, Suppurative; Otitis Media, Purulent |
Sanofi |
2006-01 | PHASE3 |
| NCT00232154 | COMPLETED | Sinusitis |
Pfizer |
2005-11 | PHASE2 |
| NCT00324818 | COMPLETED | Bacterial Vaginosis |
University of Alabama at Birmingham |
2002-07 | PHASE4 |
| NCT00830336 | COMPLETED | Healthy |
Teva Pharmaceuticals USA |
2005-10 | PHASE1 |
| NCT00610623 | TERMINATED | Pneumonia, Ventilator-Associated; Pseudomonas Infections |
Anbics Management-Services Ag |
2003-04 | PHASE2 |
| NCT00299208 | COMPLETED | Plasmodium Falciparum Malaria |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE2 | |
| NCT00057486 | TERMINATED | HIV Infections; Cryptosporidiosis |
National Institute of Allergy and Infectious Diseases (NIAID) |
1997-09 | PHASE1; PHASE2 |
| NCT00001128 | TERMINATED | Cryptosporidiosis; HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
||
| NCT00649935 | COMPLETED | Healthy |
Mylan Pharmaceuticals Inc |
2005-05 | PHASE1 |
| NCT00650273 | COMPLETED | Healthy |
Mylan Pharmaceuticals Inc |
2005-04 | PHASE1 |
| NCT00875966 | COMPLETED | Infections |
Sandoz |
2004-08 | PHASE1 |
| NCT00538148 | COMPLETED | Bronchitis, Chronic |
Sanofi |
2002-11 | PHASE4 |
| NCT00645112 | COMPLETED | Acute Otitis Media |
Abbott |
2003-11 | PHASE4 |
| NCT00347776 | COMPLETED | Trichiasis |
Johns Hopkins University |
2001-08 | PHASE4 |
| NCT00865670 | COMPLETED | Infection |
Sandoz |
2003-08 | PHASE1 |
| NCT00866216 | COMPLETED | Infection |
Sandoz |
2003-08 | PHASE1 |
| NCT00359970 | COMPLETED | Diarrhea |
The University of Texas Health Science Center, Houston |
2002-06 | PHASE4 |
| NCT00644774 | COMPLETED | Healthy |
Abbott |
2003-01 | PHASE4 |
| NCT00834756 | COMPLETED | Healthy |
Teva Pharmaceuticals USA |
2002-09 | PHASE1 |
| NCT00834132 | COMPLETED | Healthy |
Teva Pharmaceuticals USA |
2002-07 | PHASE1 |
| NCT00644176 | COMPLETED | Pharmacokinetics |
Pfizer |
2004-11 | PHASE2 |
| NCT00471809 | TERMINATED | Asthma |
National Heart, Lung, and Blood Institute (NHLBI) |
2006-03 | PHASE4 |
| NCT00323986 | TERMINATED | COPD; Tracheostomy |
University of Milan |
2004-10 | PHASE2 |
| NCT00648726 | COMPLETED | Pneumonia |
Pfizer |
2003-01 | PHASE3 |
| NCT00821782 | COMPLETED | Healthy Volunteer |
Ortho-McNeil Janssen Scientific Affairs, LLC |
2006-06 | PHASE1 |
| NCT00245440 | TERMINATED | Maxillary Sinusitis |
CPL Associates |
2005-12 | PHASE4 |
| NCT00001023 | COMPLETED | Mycobacterium Avium-intracellulare Infection; HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
||
| NCT00082563 | TERMINATED | Malaria, Falciparum |
Pfizer |
2004-08 | PHASE2 |
| NCT00357773 | COMPLETED | Conjunctivitis, Bacterial |
Laboratoires Thea |
2004-05 | PHASE3 |
| NCT00357539 | COMPLETED | Eye Infections, Bacterial |
Laboratoires Thea |
2002-02 | PHASE1 |
| NCT00000895 | COMPLETED | Mycobacterium Avium-intracellulare Infection; HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
||
| NCT00035347 | COMPLETED | Community-Acquired Pneumonia (CAP) |
Pfizer |
2001-01 | PHASE4 |
| NCT00000641 | COMPLETED | Mycobacterium Avium-intracellulare Infection; HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE2 | |
| NCT00084240 | TERMINATED | Malaria, Falciparum |
Pfizer |
2004-03 | PHASE2; PHASE3 |
| NCT00643149 | COMPLETED | Tonsillitis |
Pfizer |
2003-05 | PHASE3 |
| NCT00357292 | COMPLETED | Eye Infections, Bacterial |
Laboratoires Thea |
2002-03 | PHASE1 |
| NCT00164112 | COMPLETED | Healthy |
Bassett Healthcare |
2004-11 | PHASE4 |
| NCT00002192 | COMPLETED | Mycobacterium Avium-Intracellulare Infection; HIV Infections |
Anderson Clinical Research |
PHASE2 | |
| NCT00644449 | COMPLETED | Bronchitis, Chronic |
Pfizer |
2003-01 | PHASE3 |
| NCT00153634 | COMPLETED | Cystic Fibrosis; Chronic Bronchitis |
Seattle Children's Hospital |
2004-03 | |
| NCT00002122 | COMPLETED | Mycoses; Mycobacterium Avium-Intracellulare Infection; HIV Infections |
Pfizer |
PHASE3 | |
| NCT00649831 | COMPLETED | Bronchitis, Chronic |
Pfizer |
2002-10 | PHASE3 |
| NCT00367120 | COMPLETED | Sinusitis |
Pfizer |
2006-06 | PHASE4 |
| NCT00074841 | COMPLETED | PLASMODIUM FALCIPARUM MALARIA |
Pfizer |
2003-09 | PHASE2; PHASE3 |
| NCT00644293 | COMPLETED | Pharyngitis; Tonsillitis |
Pfizer |
2003-01 | PHASE3 |
| NCT00000811 | COMPLETED | Bacterial Infections; Pneumonia, Pneumocystis Carinii; HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE2 | |
| NCT00002082 | COMPLETED | Cryptosporidiosis; HIV Infections |
Pfizer |
||
| NCT00002085 | COMPLETED | Mycobacterium Avium-Intracellulare Infection; HIV Infections; Tuberculosis, Mycobacterium Infection |
Pfizer |
||
| NCT00084227 | COMPLETED | Malaria, Falciparum |
Pfizer |
2004-07 | PHASE2; PHASE3 |
| NCT00643734 | COMPLETED | Pneumonia |
Pfizer |
2003-04 | PHASE3 |
| NCT00002309 | COMPLETED | Mycobacterium Avium-Intracellulare Infection; HIV Infections |
Pfizer |
||
| NCT00643409 | COMPLETED | Maxillary Sinusitis |
Pfizer |
2003-01 | PHASE3 |
| NCT00000947 | COMPLETED | Mycobacterium Avium-intracellulare Infection; HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
||
| NCT00002090 | COMPLETED | Mycobacterium Avium-Intracellulare Infection; HIV Infections |
Pfizer |
||
| NCT00356772 | COMPLETED | Eye Infections, Bacterial |
Laboratoires Thea |
2003-02 | PHASE1 |
| NCT00643292 | COMPLETED | Acute Otitis Media |
Pfizer |
2003-01 | PHASE3 |
| NCT00127504 | COMPLETED | Onchocerciasis |
Centers for Disease Control and Prevention |
2003-07 | PHASE2 |
| NCT00245908 | COMPLETED | Asthma |
Wisconsin Research Network |
1999-09 | PHASE3 |
| NCT00000883 | COMPLETED | Mycobacterium Avium-intracellulare Infection; HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
1997-10 | |
| NCT00563251 | COMPLETED | Bronchiolitis Obliterans; Bone Marrow Transplantation |
Hospital Authority, Hong Kong |
2005-04 | |
| NCT00137007 | COMPLETED | Pneumonia |
Pfizer |
2003-11 | PHASE4 |
| NCT00357383 | COMPLETED | Eye Infections, Bacterial |
Laboratoires Thea |
2002-10 | PHASE1 |
| NCT00042718 | COMPLETED | Bronchitis; Chronic Bronchitis |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
2001-11 | PHASE3 |
| NCT00229944 | COMPLETED | Cholera |
International Centre for Diarrhoeal Disease Research, Bangladesh |
2002-12 | PHASE3 |
| NCT00643227 | COMPLETED | Pneumonia |
Pfizer |
2003-01 | PHASE3 |
| NCT00245453 | WITHDRAWN | Pneumonia, Bacterial; Bronchitis, Chronic |
CPL Associates |
2005-10 | PHASE4 |
| NCT00356850 | COMPLETED | Eye Infections, Bacterial |
Laboratoires Thea |
2002-05 | PHASE1 |
| NCT00002328 | COMPLETED | Cryptosporidiosis; HIV Infections |
Pfizer |
||
| NCT00000617 | COMPLETED | Coronary Disease; Heart Diseases; Myocardial Infarction; Cardiovascular Diseases |
National Heart, Lung, and Blood Institute (NHLBI) |
1998-09 | PHASE3 |
| NCT00132860 | UNKNOWN | Pulmonary Disease, Chronic Obstructive |
Odense University Hospital |
2001-05 | PHASE4 |
| NCT00140023 | COMPLETED | Community-Acquired Pneumonia |
Pfizer |
2005-09 | PHASE3 |
| NCT00643539 | COMPLETED | Tonsillitis |
Pfizer |
2002-12 | PHASE4 |
| NCT00043264 | COMPLETED | Multiple Sclerosis |
National Center for Research Resources (NCRR) |
PHASE2 |
(data from https://clinicaltrials.gov, updated on 2025-06-13)
Check the
Azithromycin Dihydrate
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
- Azithromycin Dihydrate Solubility in DMSO
- Azithromycin Dihydrate Stock Solution
- Azithromycin Dihydrate Storage
- Azithromycin Dihydrate Stability
- Azithromycin Dihydrate Molecular Weight
- Azithromycin Dihydrate SMILES
- Azithromycin Dihydrate CAS Number
- Azithromycin Dihydrate Chemical Structure (2D and 3D)
- Azithromycin Dihydrate SDS｜MSDS
Note: Technical data last updated: Sep 1, 2026.